ResearchBib Share Your Research, Maximize Your Social Impacts
Sign for Notice Everyday Sign up >> Login

21 CFR Part 11 Guidance 2020 - 21 CFR Part 11 Guidance on Electronic Records and Electronic Signatures for Computer Systems Regulated by FDA

Date2020-03-23

Deadline2020-03-23

VenueOnline Event, USA - United States USA - United States

KeywordsPharmaceutical; Medical Device; Biotechnology

Websitehttps://www.compliancekey.us/webinarDeta...

Topics/Call fo Papers

Topic : 21 CFR Part 11 Guidance on Electronic Records and Electronic Signatures for Computer Systems Regulated by FDA
Register : https://www.compliancekey.us/webinarDetails?indust...
Discount Coupon : Use this Coupon (NEW2COMPLIANCE) and get (10% Off) On New Signup
Overview
This webinar will help you understand in detail the application of FDA's 21 CFR Part 11 guidance on electronic records/electronic signatures (ER/ES) for computer systems subject to FDA regulations. This is critical in order to develop the appropriate validation strategy and achieve the thoroughness required to prove that a system does what it purports to do. It also ensures that a system is maintained in a validated state throughout its entire life cycle, from conception through retirement.
Areas Covered in the Session :
Gain an understanding of FDA's 21 CFR Part 11 Electronic Records/Electronic Signatures (ER/ES) guidance document
Develop the ability to apply 21 CFR Part 11 when implementing, validating and maintaining computer systems in your organization
Understand the best practices for maintaining a computer system with ER/ES capability in a validated state
Discuss the best practices necessary to ensure all systems with ER/ES capability are validated appropriately
Learn how to develop the appropriate computer validation strategy, to ensure a good balance of cost vs. risk, as it applies to the use of ER/ES capability
Speaker Profile :
Carolyn Troiano is Keynote Spe aker at ComplianceKey.She has more than 30 years of experience during which she worked directly, or as a consultant, for many top-tier pharmaceutical, medical device and biological companies in the US and Europe. She was responsible for computer system validation compliance activities across all GxP functions at a major pharmaceutical company. She developed computer system validation programs and strategies and was an industry reviewer for 21 CFR Part 11, the FDA's electronic record/electronic signature (ER/ES) regulation.
Contact Info :
Compliance Key
https://www.compliancekey.us/
Email :support-AT-compliancekey.us
Phone : +1 717-208-8666

Last modified: 2020-03-16 16:40:02